Bouwman, Femke http://orcid.org/0000-0002-0527-2270
,
Orini, Stefania
Gandolfo, Federica
Altomare, Daniele
Festari, Cristina
Agosta, Federica
Arbizu, Javier
Drzezga, Alexander
Nestor, Peter
Nobili, Flavio
Walker, Zuzana
Morbelli, Silvia
Boccardi, Marina
Funding for this research was provided by:
VU University Medical Center
Article History
Received: 12 April 2018
Accepted: 16 April 2018
First Online: 9 May 2018
Compliance with ethical standards
:
: Flavio Nobili: received personal fees and non-financial support from GE Healthcare, non-financial support from Eli-Lilly and grants from Chiesi Farmaceutici.Cristina Festari: declares that she has no conflict of interest.Daniele Altomare was the recipient of the grant allocated by the European Academy of Neurology (EAN) for data extraction and evidence assessment for the present project.Federica Agosta: is Section Editor of NeuroImage: Clinical; has received speaker fees from Biogen Idec, Novartis, and Excellence in Medical Education; and receives or has received research supports from the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA), and the European Research Council. She received personal fees from Elsevier INC.Stefania Orini: declares that she has no conflict of interest.Federica Gandolfo: declares that she has no conflict of interest.Javier Arbizu: received grants from Eli-Lilly & Co, Piramal and GE Healthcare.Femke Bouwman: none.Peter Nestor: received radiotracer from Piramal at a discounted rate as part of a research collaboration.Alexander Drzezga: received grants and non-financial support from Eli-Lilly & Co, Siemens and GE Healthcare; he also received non-financial support from Piramal.Zuzana Walker: received from GE Healthcare grants and tracers, personal fees for consultancy and speaker’s fee.Marina Boccardi has received funds from the European Association of Nuclear Medicine (EANM) to perform the evidence assessment and the global coordination of the present project. Moreover, she has received research grants from Piramal and served as a paid member of advisory boards for Eli Lilly.Giovanni B. Frisoni is principal investigator of industry-sponsored trials funded by AbbVie, Acadia, Altoida, Amoneta, Araclon, Biogen, Janssen, Novartis, Piramal; has received funding for investigator-initiated trials from GE, Piramal, and Avid-Lilly; has received speaker’s fees from a number of pharma and imaging companies.
: This article does not contain any new studies with human participants or animals performed by any of the authors. The human studies discussed herein came exclusively from previously published research articles.
: Not applicable, this is a review article. Informed consent statement is declared in each of the revised paper.